KEY HIGHLIGHTS
- 2Q26 revenue USD 2,945 Mn, +22.5% QoQ and +28.5% YoY, yet 1H26 revenue of USD 5,349 Mn is only 45.1% of FY26F consensus, a miss: reaching it needs 2H26 up 21.8% on 1H26.
- EBITDA USD 381 Mn in 2Q26, -9.4% QoQ, takes 1H26 to USD 803 Mn, 55.1% of FY26F and a beat; core operating income is in-line at 49.1%.
- 2Q26 net profit USD 137 Mn, -6.2% QoQ, leaves 1H26 at 40.3% of FY26F, the weakest line; the -89.3% YoY is optical, as 1H25 held a USD 1,772 Mn bargain purchase gain.
- Our read: mixed, but the line that beat is the one that matters. Consensus revenue looks too high while margin runs ahead: 1H26 EBITDA margin 15.0% against 12.3% implied by FY26F, and consensus needs 2H26 EBITDA 8.4% below 1H26. Chemical stays the drag at a USD 169 Mn 1H26 segment loss. At 2.5x P/BV against an 8.9x five-year mean and 3.5x -1SD, the stock sits below its own trough band. Key watch: whether refining margin holds into 3Q26.